
Study
Nutriventia announces new study demonstrating how 250 mg of TurmXTRA™ significantly improves joint comfort and function in individuals with mild to moderate knee osteoarthritis
Mumbai, India (February 23, 2025) – Nutriventia, a pioneer in consumer-centric nutraceutical innovations, today announced the results of a new clinical trial evaluating its patented TurmXTRA™ 60N, a low-dose, water-dispersible turmeric extract, for the management of mild-to-moderate knee osteoarthritis (OA). According to Rajat Mittal Shah, Co-founder, Nutriventia, “TurmXTRA™ 60N has